Adam Sowalsky

40PUBLICATIONS

286CO-AUTHORS

Molecular targetsLiquid biopsiesPredictive and prognostic markersCancer diagnosisInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (40)

Sort by Publication Date:

|May 12, 2026

TMPRSS2-ERG confers resistance of prostate cancer to antiandrogens.

|Apr 22, 2026

TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies.

|Mar 25, 2026

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer.

Chennan Li, Ravi A Madan, Min-Jung Lee

|Feb 12, 2026

Integrative dual ctDNA 5mC/5hmC methylomics and clonal reconstruction infer tumor transcription and resistance phenotypes in metastatic prostate cancer.

Chennan Li, Anna Baj, Clara C Y Seo

|Jan 16, 2026

Molecular decoupling of lineage identity and morphology in aggressive variant prostate cancer.

Chennan Li, JuanJuan Yin, Melissa L Abel

|Jan 13, 2026

MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer.

Surendra Gulla, Tej Sharma, Ephraim Gardner

Pageof 7

Frequent Collaborators

17 joint publications

Scott Wilkinson

Steven P Balk

Fatima Karzai

Anson T Ku

William Figg

Nicole V Carrabba

James L Gulley

Caroline S Jansen

Shana Y Trostel

Rosina T Lis

Frequent Collaborators

17 joint publications

Scott Wilkinson

9 joint publications

Steven P Balk

7 joint publications

Fatima Karzai

7 joint publications

Anson T Ku